Pluri Inc. Marketable Securities, Unrealized Gain (Loss), Excluding Other-than-temporary Impairment Loss
Pluri Inc. (PLUR) reported Marketable Securities, Unrealized Gain (Loss), Excluding Other-than-temporary Impairment Loss of $52.00 thousand for the 9-month period ending 2012-03-31, per its 10-Q filed 2012-05-08.
Discontinued › Income Statement › Other Income
us-gaap:MarketableSecuritiesUnrealizedGainLossExcludingOtherThanTemporaryImpairments · last filed 2012-05-08
- Pluri Inc. marketable securities, unrealized gain (loss), excluding other-than-temporary impairment loss for the quarter ending 2012-03-31 was $186.00K.
- Pluri Inc. marketable securities, unrealized gain (loss), excluding other-than-temporary impairment loss for the quarter ending 2011-12-31 was -$135.00K.
- Pluri Inc. marketable securities, unrealized gain (loss), excluding other-than-temporary impairment loss for the quarter ending 2011-09-30 was $1.00K.
| Period end | Marketable Securities, Unrealized Gain (Loss), Excluding Other-than-temporary Impairment Loss 3 month | Marketable Securities, Unrealized Gain (Loss), Excluding Other-than-temporary Impairment Loss 6 month | Marketable Securities, Unrealized Gain (Loss), Excluding Other-than-temporary Impairment Loss 9 month |
|---|---|---|---|
| 2012-03-31 | $186.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-05-08 | $51.00K derived: sum of 2 quarters · filed 2012-05-08 | $52.00K 10-Q · filed 2012-05-08 |
| 2011-12-31 | -$135.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-02-09 | -$134.00K 10-Q · filed 2012-02-09 | |
| 2011-09-30 | $1.00K 10-Q · filed 2011-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B |